This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
ADRB3 · Western blot design guide
ADRB3 Western Blot Planning Guide
Plan an ADRB3 Western blot around the catalog-observed 43.5 kDa band, image-backed A02104-3 evidence, HPA controls, and verified protocol records.
Evidence assembled July 2026 · For research use; verify linked source records and product datasheet before use
ADRB3 Western Blot Experimental Design Guide
Expected bands, documented protocol parameters, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before running
| Expected band | 43.5 kDa | |
| Observed band | Not reported — verify product WB image | |
| Gel | 12-15% | |
| Positive control | Brown adipose tissue | |
| Negative control | Adrenal gland |
Important caveats
Reasons your observed band may differ from the expected size.
| ⓘ | Calculated mass | 43.5 kDa |
| ⓘ | Localization | Cell membrane |
| ⓘ | Processing / PTM | Record-dependent |
| ⓘ | Reactivity | Human / Mouse / Rat |
Section 1
Real Curated ADRB3 Western Blot Protocols
Start with the molecular-weight rule, then compare verified publication-derived conditions.
| Sample / lysate | Brown adipose tissue |
| Gel % | 12-15% |
| Load | 20-30 µg total protein per lane |
| Transfer | Semi-dry, standard transfer |
| Membrane | 0.45 µm PVDF |
| Blocking | 5% non-fat milk or 5% BSA in TBST |
| Primary | A02104-3 at datasheet starting dilution |
| Primary incubation | Overnight at 4 °C with gentle agitation |
| Secondary | Species-matched HRP conjugate at validated dilution |
| Wash | 3 × 5 min in TBST |
| Detection | Chemiluminescent substrate |
| Exposure | Bracket exposures to avoid saturation |
Section 2
What Is the Expected ADRB3 Western Blot Band Size?
Use the product-observed 43.5 kDa band as the primary planning value and retain the UniProt calculated mass as context.
| 43.5 kDa | Matches the authoritative product WB observation. |
| 43.5 kDa calculated | Use as UniProt context, not as a replacement observed band. |
| Unexpected additional signal | Do not assign identity without orthogonal positive/negative controls. |
💡Expected ADRB3 appearancePlan around 43.5 kDa and keep the calculated mass as supporting context.
| Catalog-observed band | 43.5 kDa; use this as the primary experimental expectation. |
| Calculated mass | 43.5 kDa from UniProt P13945; retain as context. |
| Gel selection | 12-15%; shared with the recommended protocol and poster. |
| Specificity check | Compare the lead HPA positive and negative controls with A02104-3. |
| Situation | Likely cause | Next action |
|---|---|---|
| 43.5 kDa | Matches the authoritative product WB observation. | Confirm with orthogonal controls and the linked product record. |
| Additional band | May reflect processing, modification, or non-specific signal. | Run a dilution series and compare positive/negative controls. |
| Weak signal | Target abundance or transfer may be limiting. | Verify transfer, increase positive-control abundance, and bracket exposure. |
Experiment evidence
Western blot images showing ADRB3 band
A02104-3 · ADRB3
← swipe / scroll for more images →
Real WB data behind the band-size expectations in this section.
Sample controls for ADRB3 Western blot
🧪Use Brown adipose tissue as the first positive-control candidate and Adrenal gland as the HPA Not detected negative candidate.
Positive control: Brown adipose tissue (Medium)
Negative control: Adrenal gland (Not detected)
HPA protein score determines control status; other expression data is supporting context only.
HPA tissue expression evidence for ADRB3
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Section 3
Advanced ADRB3 Western Blot Tips
Deeper troubleshooting and optimisation questions for ADRB3, answered from its protein features.
Which band should guide the blot?
Use 43.5 kDa, the observation attached to the authoritative A02104-3 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 43.5 kDa expectation.
Which positive control should I start with?
Start with Brown adipose tissue, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use Adrenal gland as an orthogonal HPA Not detected candidate.
Which gel should I use?
Use 12-15% consistently across the quick facts, protocol table, and poster.
What transfer method to use for ADRB3 Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should A02104-3 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
Compare only the supplied target-verified records: PMC7866688, PMC8831559, PMC1892055.
Boster reagents
ADRB3 Western Blot Reagents
Human/Mouse/Rat-reactive ADRB3 Western blot reagents with authoritative product imagery.
Real WB data
Anti-beta 3 Adrenergic Receptor/ADRB3 Antibody Picoband®
Cat # A02104-3
Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.
Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.
References
- UniProt P13945
- Human Protein Atlas — ADRB3
- A02104-3 product record
- PMC7866688 — The crosstalk of HDAC3, microRNA-18a and ADRB3 in the progression of heart failure.
- PMC8831559 — ADRB3 induces mobilization and inhibits differentiation of both breast cancer cells and myeloid-derived suppressor cells.
- PMC1892055 — Is the beta3-adrenoceptor (ADRB3) a potential target for uterorelaxant drugs?